NATURAL HEALTH TRENDS CORP (NHTC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 6M 12M 18M Q2 '21: 16.2M Q3 '21: 14.3M Q4 '21: 16.1M Q1 '22: 11.5M Q2 '22: 13.4M Q3 '22: 11.7M Q4 '22: 12.5M Q1 '23: 11.9M Q2 '23: 10.5M Q3 '23: 10.6M Q4 '23: 10.9M Q1 '24: 11M Q2 '24: 10.5M Q3 '24: 10.7M Q4 '24: 10.8M Q1 '25: 10.7M Q2 '25: 9.8M Q3 '25: 9.5M Q4 '25: 9.7M Q1 '26: 9.2M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Gross Profit Quarterly

0 5M 10M 15M Q2 '21: 12.2M Q3 '21: 10.6M Q4 '21: 12M Q1 '22: 8.6M Q2 '22: 10M Q3 '22: 8.6M Q4 '22: 9.2M Q1 '23: 8.8M Q2 '23: 7.8M Q3 '23: 7.9M Q4 '23: 8.1M Q1 '24: 8M Q2 '24: 7.8M Q3 '24: 7.9M Q4 '24: 8M Q1 '25: 7.9M Q2 '25: 7.3M Q3 '25: 7M Q4 '25: 7.1M Q1 '26: 6.9M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Operating Income Quarterly

-900K -600K -300K 0 300K 600K 900K Q2 '21: 385K Q3 '21: 479K Q4 '21: 487K Q1 '22: -383K Q2 '22: 215K Q3 '22: -145K Q4 '22: 43K Q1 '23: -394K Q2 '23: -743K Q3 '23: -292K Q4 '23: -242K Q1 '24: -365K Q2 '24: -238K Q3 '24: -275K Q4 '24: -421K Q1 '25: -345K Q2 '25: -333K Q3 '25: -495K Q4 '25: -635K Q1 '26: -474K Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Net Income Quarterly

-600K -400K -200K 0 200K 400K 600K Q2 '21: 229K Q3 '21: 471K Q4 '21: 232K Q1 '22: -105K Q2 '22: 183K Q3 '22: 47K Q4 '22: 188K Q1 '23: 257K Q2 '23: -219K Q3 '23: 172K Q4 '23: 358K Q1 '24: 188K Q2 '24: 173K Q3 '24: 35K Q4 '24: 176K Q1 '25: 122K Q2 '25: 15K Q3 '25: -431K Q4 '25: -588K Q1 '26: -154K Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Cost of Revenue Quarterly

0 1.5M 3M 4.5M Q2 '21: 3.9M Q3 '21: 3.7M Q4 '21: 4.2M Q1 '22: 2.9M Q2 '22: 3.4M Q3 '22: 3.1M Q4 '22: 3.3M Q1 '23: 3M Q2 '23: 2.7M Q3 '23: 2.7M Q4 '23: 2.8M Q1 '24: 2.9M Q2 '24: 2.7M Q3 '24: 2.8M Q4 '24: 2.8M Q1 '25: 2.8M Q2 '25: 2.6M Q3 '25: 2.5M Q4 '25: 2.6M Q1 '26: 2.3M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Operating Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q2 '21: 134K Q3 '21: -1.1M Q4 '21: 1.6M Q1 '22: -2.3M Q2 '22: -1.2M Q3 '22: -2.3M Q4 '22: 938K Q1 '23: -696K Q2 '23: -2.6M Q3 '23: -869K Q4 '23: -69K Q1 '24: 549K Q2 '24: -3.6M Q3 '24: -436K Q4 '24: 88K Q1 '25: 484K Q2 '25: -5.6M Q3 '25: 113K Q4 '25: -959K Q1 '26: -797K Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Free Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q2 '21: 50K Q3 '21: -1.1M Q4 '21: 1.5M Q1 '22: -2.4M Q2 '22: -1.2M Q3 '22: -2.3M Q4 '22: 925K Q1 '23: -703K Q2 '23: -2.7M Q3 '23: -887K Q4 '23: -83K Q1 '24: 538K Q2 '24: -3.6M Q3 '24: -443K Q4 '24: 68K Q1 '25: 468K Q2 '25: -5.6M Q3 '25: 70K Q4 '25: -964K Q1 '26: -912K Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 4M 8M 12M Q3 '19: 10.6M Q1 '20: 10.5M Q2 '20: 11.4M Q3 '20: 11.4M Q1 '21: 11.4M Q2 '21: 11.4M Q3 '21: 11.4M Q1 '22: 11.3M Q2 '22: 11.4M Q3 '22: 11.4M Q1 '23: 11.4M Q2 '23: 11.4M Q3 '23: 11.5M Q1 '24: 11.5M Q2 '24: 11.5M Q3 '24: 11.5M Q1 '25: 11.5M Q2 '25: 11.5M Q3 '25: 11.5M Q1 '26: 10.1M Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.12 -0.06 0.00 0.06 0.12 0.18 Q2 '21: 0.15 Q3 '21: 0.13 Q4 '21: 0.09 Q1 '22: 0.07 Q2 '22: 0.07 Q3 '22: 0.03 Q4 '22: 0.03 Q1 '23: 0.06 Q2 '23: 0.02 Q3 '23: 0.04 Q4 '23: 0.05 Q1 '24: 0.05 Q2 '24: 0.09 Q3 '24: 0.07 Q4 '24: 0.06 Q1 '25: 0.05 Q2 '25: 0.03 Q3 '25: -0.01 Q4 '25: -0.08 Q1 '26: -0.11 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.